Dietary carbohydrate enhances intestinal sugar transport in diabetic mice.
The rate of intestinal absorption of sugars and their site of absorption determine postprandial plasma glucose concentrations. Does chronic consumption of high-carbohydrate, high-fiber, low-fat diets of the type recommended by many diabetes associations induce adaptive changes in transport and metabolism of sugars in the small intestine? Control and STZ-induced diabetic (> 60 days diabetic) mice were fed high-carbohydrate or no-carbohydrate rations for 7 days. Brush-border glucose and fructose uptake per milligram increased 2 times with dietary carbohydrate in both diabetic and control mice; uptake, however, did not differ between diabetic and control mice. Compared with the distal small intestine, glucose uptake per milligram was 2 to 6 times higher in the proximal and middle regions, and enhancement of uptake by diet was limited to these regions. Changes in site density of intestinal glucose transporters as determined by specific phlorizin binding were tightly correlated with changes in brush-border glucose uptake per milligram. There were neither diabetes- nor diet-induced changes in the Kd of specific phlorizin binding, in the amount of glucose absorbed per transporting site, or in passive glucose permeability. Intestinal weights, wt/cm, intestinal length, and mucosal mass increased significantly with diabetes, and sugar transport per centimeter and per small intestine was up to 60% greater in diabetic mice. Dietary carbohydrate stimulated specific sucrase activity in the proximal small intestine of both diabetic and control mice. Chronic diabetes enhances sugar transport by nonspecific increases in intestinal mass.(ABSTRACT TRUNCATED AT 250 WORDS)
Ferraris
R P
RP
Department of Physiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark 07103-2714.
Casirola
D M
DM
Vinnakota
R R
RR
D000818:Animals; D001692:Biological Transport / Q000502:physiology; D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight; D002241:Carbohydrates / Q000493:pharmacokinetics*; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism / Q000503:physiopathology*; D004040:Dietary Carbohydrates / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005632:Fructose / Q000493:pharmacokinetics; D005947:Glucose / Q000493:pharmacokinetics; D006965:Hyperplasia / Q000473:pathology; D007408:Intestinal Absorption / Q000502:physiology; D007413:Intestinal Mucosa / Q000378:metabolism / Q000502:physiology / Q000648:ultrastructure; D007421:Intestine, Small / Q000737:chemistry / Q000196:embryology / Q000502:physiology*; D008297:Male; D051379:Mice; D008871:Microvilli / Q000378:metabolism / Q000502:physiology / Q000648:ultrastructure; D009004:Monosaccharide Transport Proteins / Q000032:analysis / Q000502:physiology; D013311:Streptozocin; D013393:Sucrase / Q000502:physiology
D001786:Blood Glucose; D002241:Carbohydrates; D004040:Dietary Carbohydrates; D009004:Monosaccharide Transport Proteins; D005632:Fructose; D013311:Streptozocin; D013393:Sucrase; D005947:Glucose